Avrobio Inc. (AVRO) PT Lowered to $37 at Morgan Stanley
Tweet
Share
E-mailGet Alerts AVRO Hot Sheet
Price: $1.40 --0%
Rating Summary:
9 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Rating Summary:
9 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz lowered the price target on Avrobio Inc. (NASDAQ: AVRO) to $37.00 (from $40.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Rapport Therapeutics (RAPP) PT Raised to $75 at Raymond James
- Barclays Downgrades Murphy Oil Corp. (MUR) to Underweight
- Reddit (RDDT) PT Raised to $205 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
